Table 2.
Antibiotic resistance patterns of isolates (number showing resistance / isolates with antibiotic sensitivity data available)
| |
Consolidation 1 |
Consolidation 2 |
|---|---|---|
| (% of isolates) | (% of isolates) | |
| CNST |
20 (37.7%) |
23 (32.4%) |
|
Vancomycin resistant |
1 / 15 |
0 / 21 |
| Cloxacillin resistant |
14 / 17 |
21 / 22 |
|
Streptococcus species |
9 (17%) |
17 (23.9%) |
| Penicillin resistant |
1 / 7 |
0 / 11 |
| Vancomycin resistant |
0 / 3 |
0 / 6 |
| Gram Negatives |
11 (20.7%) |
20 (28.1%) |
|
Ciprofloxacin resistant |
2 / 10 |
8 / 15 |
| P/T* resistant |
1 / 10 |
0 / 14 |
| Ampicillin resistant |
9 / 9 |
13 / 15 |
| Tobramycin resistant |
1 / 8 |
3 / 10 |
|
Klebsiella species |
2 (3.8%) |
5 (7.0%) |
| Ciprofloxacin resistant |
0/2 |
0 / 4 |
| P/T* resistant |
0/2 |
0 / 4 |
| Ampicillin resistant |
2/2 |
4 / 4 |
| Tobramycin resistant |
0/2 |
0 / 3 |
|
Escherichia coli |
1 (1.9%) |
10 (14.1%) |
|
Ciprofloxacin resistant |
1/1 |
8 / 8 |
| P/T* resistant |
0 / 1 |
0 / 8 |
| Ampicillin resistant |
1 / 1 |
7 / 8 |
| Tobramycin resistant |
1/1 |
3 / 5 |
|
Pseudomonas species |
4 (7.6%) |
- |
| Ciprofloxacin resistant |
1 / 4 |
- |
| P/T* resistant |
1/1 |
- |
| Ampicillin resistant |
3/3 |
- |
| Tobramycin resistant | 0 / 4 | - |
*P/T = Piperacillin/tazobactam.